Toxicity and Drug Testing
Modern drug design and testing involves experimental in vivo and in vitro measurement of the drug candidate's ADMET (adsorption, distribution, metabolism, elimination and toxicity) properties in the early stages of drug discovery. Only a small percentage of the proposed drug candidates receive gover...
| Autor principal: | |
|---|---|
| Formato: | Libro |
| Publicado: |
IntechOpen
2019
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=nlebk&AN=4007364&site=ehost-live header: @attributes: shortDbName: nlebk uiTerm: 4007364 longDbName: eBook Collection (EBSCOhost) uiTag: AN controlInfo: bkinfo: btl: Toxicity and Drug Testing aug: au: Bill Acree isbn: 9789535100041 9789535143635 imageinfo: pubinfo: dt: @attributes: year: 2019 month: 01 day: 01 dtAvail: @attributes: year: 2024 month: 11 day: 08 pub: IntechOpen pubContract: Intech Open place: [Place of publication not identified] price: 0.01 limitsGroup: maxCheckoutDays: 1500 pda: N printPagesOffline: 100 printPagesOnline: 100 previewPages: 10000 prePubGroup: dewey: @attributes: class: 615.9 item: 615 .9 lc: @attributes: class: RA1238 item: RA 1238 artinfo: ui: 4007364 846970067 formats: fmt: @attributes: type: EB doid: NL$4007364$PDF caption: PDF download: Y tig: atl: Toxicity and Drug Testing ptl: Toxicity and Drug Testing aug: au: Bill Acree su: Drugs--Toxicology Drugs--Testing sug: subj: MEDICAL / Toxicology Drugs--Toxicology Drugs--Testing ab: Modern drug design and testing involves experimental in vivo and in vitro measurement of the drug candidate's ADMET (adsorption, distribution, metabolism, elimination and toxicity) properties in the early stages of drug discovery. Only a small percentage of the proposed drug candidates receive government approval and reach the market place. Unfavorable pharmacokinetic properties, poor bioavailability and efficacy, low solubility, adverse side effects and toxicity concerns account for many of the drug failures encountered in the pharmaceutical industry. Authors from several countries have contributed chapters detailing regulatory policies, pharmaceutical concerns and clinical practices in their respective countries with the expectation that the open exchange of scientific results and ideas presented in this book will lead to improved pharmaceutical products. pubtype: eBook doctype: Book ougenre: Book language: English copyright: @attributes: flag: N copyrightText: holdings: @attributes: islocal: N |
|---|